Chemoinformaics analysis of ENT-15BETA,16-EPOXY-KAURAN-17-OL
Molecular Weight | 304.474 | nRot | 1 |
Heavy Atom Molecular Weight | 272.218 | nRig | 21 |
Exact Molecular Weight | 304.24 | nRing | 5 |
Solubility: LogS | -5.323 | nHRing | 1 |
Solubility: LogP | 4.677 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 20 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 56.3414 |
nHD | 1 | BPOL | 33.8386 |
QED | 0.738 |
Synth | 5.882 |
Natural Product Likeliness | 3.602 |
NR-PPAR-gamma | 0.061 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.081 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.938 |
MDCK | 0.0000246 |
BBB | 0.678 |
PPB | 0.959834 |
VDSS | 1.554 |
FU | 0.0364928 |
CYP1A2-inh | 0.058 |
CYP1A2-sub | 0.652 |
CYP2c19-inh | 0.055 |
CYP2c19-sub | 0.918 |
CYP2c9-inh | 0.269 |
CYP2c9-sub | 0.224 |
CYP2d6-inh | 0.037 |
CYP2d6-sub | 0.863 |
CYP3a4-inh | 0.335 |
CYP3a4-sub | 0.183 |
CL | 13.34 |
T12 | 0.08 |
hERG | 0.01 |
Ames | 0.034 |
ROA | 0.085 |
SkinSen | 0.169 |
Carcinogencity | 0.082 |
EI | 0.82 |
Respiratory | 0.959 |
NR-Aromatase | 0.833 |
Antiviral | No |
Prediction | 0.73418 |